Thu-23-11-2017, 13:18 PM
Update: The European Commission has approved Tremfya (guselkumab) for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy.
Tremfya (guselkumab)
Tremfya (guselkumab)